Brief: Rovi Ends Buy-Back Programme Of About 4.3% Share Capital

Laboratorios Farmaceuticos Rovi

11/06/2024 17:09

June 11 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * CONCLUDES BUY-BACK PROGRAMME
    * REACHES MAXIMUM MONETARY AMOUNT, THIS IS 2.2 MILLION
SHARES,
ABOUT 4.3% OF SHARE CAPITAL
    * RESUMES, AS OF JUNE 12, TRANSACTIONS UNDER LIQUIDITY
CONTRACT

Source text for Workspace:  ID:nCNMcbY0Ts 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))